Pharsight

Drugs that contain Edoxaban Tosylate

1. Savaysa patents expiration

SAVAYSA's oppositions filed in EPO
Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents protects the active chemical substance. Only drug patent owner can launch products that use this active substance.
US7365205 DAIICHI SANKYO INC Diamine derivatives
Apr, 2027

(2 years from now)

These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9149532 DAIICHI SANKYO INC Pharmaceutical composition
Mar, 2028

(3 years from now)

Drug Exclusivity Drug Exclusivity Expiration
M(M-14) Oct 18, 2026
M(M-243) Aug 09, 2022
New Chemical Entity Exclusivity(NCE) Jan 08, 2020

NCE-1 date: 08 January, 2019

Market Authorisation Date: 08 January, 2015

Treatment: NA

Dosage: TABLET;ORAL

How can I launch a generic of SAVAYSA before it's drug patent expiration?
More Information on Dosage

SAVAYSA family patents

Family Patents